|
Market Cap (19-May) $82,472,520 (825th) |
Close (30-Jun) $1.50 |
Volume (30-Jun) 19,997 |
Shortsold (12-Dec) 1,378 (0.00%) (711th) |
|
52w High $1.33 |
52w Low $1.10 |
P/E - |
EPS - |
CD3 released this announcement to the ASX on 25 June 2021, 15:55. The announcement is not marked as price sensitive, and is 70 page(s) in length and 3.94MB in size.
You can view all announcements from CD3 and see how they appear on a price chart on the announcements page.
At the date of this announcement, CD3 was 0.002% short sold according to ASIC data. It was ranked the 711th most shorted stock on the ASX. It remains ranked 711th as of the latest reported data (12 December 2022).
| Other Recent Announcements from CD3 | |
|---|---|
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:27 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:25 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:22 |
| Annual Report to Unitholders - 31 March 2021 | 25 June 2021, 15:55 |
| Change of Director's Interest Notice - Warwick Keneally | 23 June 2021, 16:34 |
| CD Private Equity Fund Series Update - June 2021 | 22 June 2021, 16:51 |
| Net Tangible Asset Backing & Fund Update | 11 June 2021, 16:14 |
You must be logged in to post a reply.
